Plunkett Research Online: Retrophin Inc

RETROPHIN INC (RTRX:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Retrophin, Inc. is an integrated biopharmaceutical company focused on the development, acquisition and commercialization of therapies for the treatment of serious, catastrophic or rare diseases. The firm currently has three products: Chenoda, approved in the U.S. for the treatment of patients suffe.....



Retrophin Inc
Ticker: RTRX
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 760-260-8600
Fax:
Address: 3721 Valley Centre Drive
Suite 200
San Diego, CA 92130 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceutical Preparation Manufacturing
ContactsDescription
Laura ClagueCFO/Chief Accounting Officer/Senior VP
Neil McFarlaneCOO
See More
Retrophin, Inc. is an integrated biopharmaceutical company focused on the development, acquisition and commercialization of therapies for the treatment of serious, catastrophic or rare diseases. The firm currently has three products: Chenoda, approved in the U.S. for the treatment of patients suffe.....See More See More

Auditor: BDO USA, LLP
Legal Advisor: Heskett & Heskett
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Chenoda
Cholbam
Thiola
Sparsentan
RE-024
RE-034
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: